Expression of ER was observed in nuclear as well as cytoplasmic lysates of breast cancer cells treated with END and ENL within 15 min of treatment while E2-treated cells showed peak expression at later time points (Figure 7C). The gene discussed is ESR1; the disease is breast carcinoma.